|
Therapeutic Drug Monitoring Conference
Citations 1-10 of 12 total displayed.
|
Most recent content
(1 Nov 2001):
|
- Endocrinology and Metabolism
The National Glycohemoglobin Standardization Program: A Five-Year Progress Report
- Randie R. Little, Curt L. Rohlfing, Hsiao-Mei Wiedmeyer, Gary L. Myers, David B. Sacks, and David E. Goldstein
Clin. Chem. 2001; 47: 1985-1992.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Feb 1998):
|
- TDM Conference
The Role of Therapeutic Drug Monitoring in Disease Management: Introduction
- Leslie M. Shaw and Michael Oellerich
Clin. Chem. 1998; 44: 369.
[Extract]
[Full text]
[PDF]
- TDM Conference
Total testing process applied to therapeutic drug monitoring: impact on patients' outcomes and economics
- Gerald E. Schumacher and Judith T. Barr
Clin. Chem. 1998; 44: 370-374.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Analytical goals in therapeutic drug monitoring
- Larry D. Bowers
Clin. Chem. 1998; 44: 375-380.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Prospective investigations of concentration–clinical response for immunosuppressive drugs provide the scientific basis for therapeutic drug monitoring
- Leslie M. Shaw, Bruce Kaplan, and Kenneth L. Brayman
Clin. Chem. 1998; 44: 381-387.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach
- Yuen Yi Hon and William E. Evans
Clin. Chem. 1998; 44: 388-400.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Strategies for physician education in therapeutic drug monitoring
- David W. Bates, Steven J. Soldin, Petrie M. Rainey, and Joseph N. Micelli
Clin. Chem. 1998; 44: 401-407.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Clinical outcome and economic impact of aminoglycoside peak concentrations in febrile immunocompromised patients with hematologic malignancies
- Lutz Binder, Xaver Schiel, Claudia Binder, Cristina Fernandes Almeida Menke, Silke Schüttrumpf, Victor W. Armstrong, Michael Unterhalt, Norbert Erichsen, Wolfgang Hiddemann, and Michael Oellerich
Clin. Chem. 1998; 44: 408-414.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Therapeutic drug monitoring in special populations
- Philip D. Walson
Clin. Chem. 1998; 44: 415-419.
[Abstract]
[Full text]
[PDF]
- TDM Conference
Development of new cancer chemoprevention agents: role of pharmacokinetic/pharmacodynamic and intermediate endpoint biomarker monitoring
- Ronald Lieberman, James A. Crowell, Ernest T. Hawk, Charles W. Boone, Caroline C. Sigman, and Gary J. Kelloff
Clin. Chem. 1998; 44: 420-427.
[Abstract]
[Full text]
[PDF]
|
|
